T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance

Department of Internal Medicine II-Cardiology, University of Ulm, Robert-Koch-Str 8, D-89081 Ulm, Germany.
Arteriosclerosis Thrombosis and Vascular Biology (Impact Factor: 6). 08/2008; 28(7):1304-10. DOI: 10.1161/ATVBAHA.108.165100
Source: PubMed


Adipose tissue inflammation may play a critical role in the pathogenesis of insulin resistance (IR). The present study examined the role of lymphocytes in adipose tissue inflammation and IR.
In a mouse model of obesity-mediated IR, high-fat diet (HFD) induced IR already after 5 weeks, which was associated with a marked T-lymphocyte infiltration in visceral adipose tissue. In contrast, recruitment of macrophages was delayed with an increase of MAC3-positive staining and F4/80 mRNA expression after 10 weeks of HFD, suggesting a dissociation of macrophage invasion into adipose tissue and IR initiation. In patients with type 2 diabetes, lymphocyte content in adipose tissue biopsies significantly correlated with waist circumference, a marker of IR. Immunohistochemical staining of human adipose tissue revealed the presence of mainly CD4-positive lymphocytes as well as macrophage infiltration. Most macrophages were HLA-DR-positive, reflecting activation through IFNgamma, a cytokine released from CD4-positive lymphocytes.
Proinflammatory T-lymphocytes are present in visceral adipose tissue and may contribute to local inflammatory cell activation before the appearance of macrophages, suggesting that these cells could play an important role in the initiation and perpetuation of adipose tissue inflammation as well as the development of IR.

Download full-text


Available from: Markus Clemenz,
1 Follower
52 Reads
  • Source
    • "3.1. Mast cells and macrophages are mobilized and are increased in number in the spleen and pancreas of obese mice Given that mast cells and other immune cell-types have been implicated in type 2 diabetes [20] [21] [31], we evaluated selected immune cell populations in the pancreas, liver, and spleen of obese mice (db/db), compared to littermate control (db/+) mice, by flow cytometry. Adult db/+ mice had an average mass of 25.1 g (±4.7) while age matched db/db mice had an average 2- fold greater mass of 52.0 g (±3.6) (Fig. 1A). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The human pathogen Chlamydia pneumoniae has been implicated in chronic inflammatory diseases including type 2 diabetes. Therefore, we designed a study to evaluate pancreatic beta cells and mast cells during chlamydial infection. Our study revealed that C. pneumoniae infected mast cells significantly (p<0.005) decreased beta cell ATP and insulin production, in contrast to uninfected mast cells co-cultured with beta cells. Infected mast cells exhibited pyknotic nuclei and active caspase-3 and caspase-1 expression. Additionally, ex vivo analyses of tissues collected from C. pneumoniae infected mice showed increased interleukin-1β production in splenocytes and pancreatic tissues as was observed with in vitro mast cell-beta cell co-cultures during C. pneumoniae infection. Notably, infected mast cells promoted beta cell destruction. Our findings reveal the negative effect of C. pneumoniae on mast cells, and the consequential impact on pancreatic beta cell function and viability. Copyright © 2015 Elsevier Inc. All rights reserved.
    Cellular Immunology 04/2015; 295(2). DOI:10.1016/j.cellimm.2015.03.010 · 1.92 Impact Factor
  • Source
    • "Oxidative Medicine and Cellular Longevity overload is signed by a profound remodeling of fat affecting all cellular components of WAT. This remodeling especially is characterized by an increased immune cells infiltration [4] [5]. Moreover, cellular stresses concomitant to fat overloading such as metabolic dysfunctions, inflammation, hypoxia, reticulum endoplasmic stress, and hypoxia will contribute to attracting and retaining inflammatory cells within the WAT (for review, [6]). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oxidative stress plays a pathological role in the development of various diseases including diabetes, atherosclerosis, or cancer. Systemic oxidative stress results from an imbalance between oxidants derivatives production and antioxidants defenses. Reactive oxygen species (ROS) are generally considered to be detrimental for health. However, evidences have been provided that they can act as second messengers in adaptative responses to stress. Obesity represents a major risk factor for deleterious associated pathologies such as type 2 diabetes, liver, and coronary heart diseases. Many evidences regarding obesity-induced oxidative stress accumulated over the past few years based on established correlations of biomarkers or end-products of free-radical-mediated oxidative stress with body mass index. The hypothesis that oxidative stress plays a significant role in the development of metabolic disorders, especially insulin-resistance state, is supported by several studies where treatments reducing ROS production reverse metabolic alterations, notably through improvement of insulin sensitivity, hyperlipidemia, or hepatic steatosis. In this review, we will develop the mechanistic links between oxidative stress generated by adipose tissue in the context of obesity and its impact on metabolic complications development. We will also attempt to discuss potential therapeutic approaches targeting obesity-associated oxidative stress in order to prevent associated-metabolic complications.
    Oxidative medicine and cellular longevity 07/2014; 2014(5-6):908539. DOI:10.1155/2014/908539 · 3.36 Impact Factor
  • Source
    • "T cells have only recently been discovered to play a role in adipose tissue inflammation. T cells are more abundant in adipose tissue from obese mice as compared to their lean counterparts and actually arrive before macrophages start accumulating [52]. Given that the cytokines that dictate the balance between M1 and M2 macrophage phenotypes are typical T cell-derived cytokines, their simultaneous influx would seem logical. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Up to 25 per cent of the world׳s adult population may have the metabolic syndrome, a condition closely associated with central obesity. The metabolic syndrome is a major risk factor for cardiovascular disease and type 2 diabetes and therefore represents an important worldwide health problem. In addition to metabolic abnormalities such as raised fasting plasma glucose, high cholesterol and high blood pressure, there is consensus that obese subjects develop a state of low-grade chronic immune activation. This sustained pro-inflammatory response in fat tissue is thought to worsen insulin resistance and dyslipidemia. Likewise, the immune system contributes to the detrimental cascade of events leading to plaque formation in atherosclerosis. It has long been assumed that the innate arm of the immune system was the only key player, but emerging evidence suggests that there is in fact a sizeable adaptive immune component to obesity and cardiovascular disease. From a therapeutic perspective, it could be envisioned that immune modulation drugs such as cytokine inhibitors, co-stimulation blockers or anti-T cell agents could offer benefit. It is questionable, however, whether chronic treatment with for instance biologicals will have a favorable risk/benefit profile in a silent condition such as the metabolic syndrome. An attractive alternative could be the development of antigen-specific T cell therapies, not unlike those currently in various phases of development for type 1 diabetes. In this article, we will give an overview of antigen-specific treatment modalities in type 1 diabetes, followed by a review of the evidence for T cell involvement in obesity and atherosclerosis.
    Molecular Metabolism 06/2014; 3(3):275-283. DOI:10.1016/j.molmet.2013.12.005
Show more